Downregulation of CerS4 Instead of CerS2 in Liver Effectively Alleviates Hepatic Insulin Resistance in HFD Male Mice
Endocrinology · 27.08.2024 · 165 (10)
DOI: 10.1210/endocr/bqae118 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endocrinology, online erschienen am 05.09.2024. Verfasst von Kamila Roszczyc-Owsiejczuk und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hygiene, Epidemiology and Metabolic Disorders, Medical University of Bialystok, 15-222 Bialystok, Poland. Hauptthemen laut MEDLINE: Diet, High-Fat, Insulin Resistance, Sphingosine N-Acyltransferase, Liver. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 71 Literaturangaben. Gefördert von: NCN.
Abstract (Originalsprache)
Objective
Consumption of a high-fat diet (HFD) induces insulin resistance (IRes), significantly affecting the maintenance of normal glucose homeostasis. Nevertheless, despite decades of extensive research, the mechanisms and pathogenesis of IRes remain incomplete. Recent studies have primarily explored lipid intermediates such as diacylglycerol (DAG), given a limited knowledge about the role of ceramide (Cer), which is a potential mediator of the IRes in the liver.
Methods
In order to investigate the role of Cer produced by CerS2 and CerS4 for the purpose of inducing the hepatic IRes, we utilized a unique in vivo model employing shRNA-mediated hydrodynamic gene delivery in the liver of HFD-fed C57BL/6J mice.
Results
Downregulation of CerS4 instead of CerS2 reduced specific liver Cers, notably C18:0-Cer and C24:0-Cer, as well as acylcarnitine levels. It concurrently promoted glycogen accumulation, leading to enhanced insulin sensitivity and glucose homeostasis.
Conclusion
Those findings demonstrate that CerS4 downregulating lowers fasting blood glucose levels and mitigates the HFD-induced hepatic IRes. It suggests that inhibiting the CerS4-mediated C18:0-Cer synthesis holds a promise to effectively address insulin resistance in obesity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hygiene, Epidemiology and Metabolic Disorders, Medical University of Bialystok, 15-222 Bialystok, Poland.
- Department of Medical Biology, Medical University of Bialystok, 15-222 Bialystok, Poland.
ORCID-Profile: Kamila Roszczyc-Owsiejczuk, Piotr Zabielski, Monika Imierska, Agnieszka Błachnio-Zabielska
Förderung
- NCN
Zitieren
APA
Roszczyc-Owsiejczuk, K., Zabielski, P., Imierska, M., Pogodzińska, K., Sadowska, P., & Błachnio-Zabielska, A. (2024). Downregulation of CerS4 Instead of CerS2 in Liver Effectively Alleviates Hepatic Insulin Resistance in HFD Male Mice. Endocrinology, 165(10). https://doi.org/10.1210/endocr/bqae118
Vancouver
Roszczyc-Owsiejczuk K, Zabielski P, Imierska M, Pogodzińska K, Sadowska P, Błachnio-Zabielska A. Downregulation of CerS4 Instead of CerS2 in Liver Effectively Alleviates Hepatic Insulin Resistance in HFD Male Mice. Endocrinology. 2024;165(10). doi:10.1210/endocr/bqae118
BibTeX
@article{RoszczycOwsiejczuk2024,
author = {Roszczyc-Owsiejczuk, Kamila and Zabielski, Piotr and Imierska, Monika and Pogodzińska, Karolina and Sadowska, Patrycja and Błachnio-Zabielska, Agnieszka},
title = {Downregulation of CerS4 Instead of CerS2 in Liver Effectively Alleviates Hepatic Insulin Resistance in HFD Male Mice},
journal = {Endocrinology},
year = {2024},
volume = {165},
number = {10},
doi = {10.1210/endocr/bqae118}
}
EUVIMED